KALV: KalVista Pharmaceuticals Inc

14.05 USD 0.23 (1.66%)

セクター: ヘルスケアベース: US Dollar 利益通貨: US Dollar

KALVの今日の為替レートは、1.66%変化しました。日中、通貨は1あたり13.68の安値と14.34の高値で取引されました。

KalVista Pharmaceuticals Incダイナミクスに従います。リアルタイムの相場は、市場の変化に迅速に対応するのに役立ちます。異なる時間枠に切り替えることで、為替レートの傾向とダイナミクスを分、時間、日、週、月単位で監視できます。この情報を使用して、市場の変化を予測し、十分な情報に基づいて取引を決定してください。

全画面チャート

KALV News

Seeking Alpha 09:02 KalVista's EKTERLY Faces Shrinking Market, Oral Competitor Threat (Downgrade) (KALV)
Investing 12:32 European regulator recommends approval of first oral HAE treatment
Investing 08:59 Kalvista Pharmaceuticals stock maintains Market Outperform rating at JMP
Investing 09:05 JMP reiterates Market Outperform rating on Kalvista stock after UK approval
Investing 20:12 UK approves first oral treatment for hereditary angioedema attacks
Seeking Alpha 19:24 Astria: Betting On Navenibart In The Crowded HAE Arena
Benzinga 12:14 Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Apple (NASDAQ:AAPL), Above Food Ingredients (NASDAQ:ABVE)
Investing 11:25 Kalvista stock maintains Buy rating at H.C. Wainwright on favorable Ekterly label
Investing 01:01 Kalvista Pharma CEO Palleiko sells $517k in shares
Investing 00:52 Kalvista Pharma chief development officer sells $474k in shares
Investing 15:15 Leerink Partners reiterates Outperform rating on Kalvista stock as Ekterly launch begins
Seeking Alpha 19:52 KalVista: FDA Approval Of EKTERLY As Oral On-Demand HAE Drug Is Just Beginning (KALV)
Benzinga 14:03 Meta Platforms To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday - Abbott Laboratories (NYSE:ABT), Danaher (NYSE:DHR)
Investing 08:53 Kalvista stock price target raised to $27 from $19 at JMP on Ekterly pricing
Investing 19:27 Kalvista stock rises as Leerink raises price target on FDA approval
Investing 18:01 Tesla, Circle Internet Surge Among Monday’s Market Cap Stock Movers
Investing 17:11 KalVista stock price target raised to $37 from $22 at BofA on Ekterly approval
Investing 14:36 Kalvista stock jumps as Stifel reiterates Buy rating on Ekterly approval
Investing 14:31 Tesla, Oracle among Monday’s market cap stock movers
Benzinga 14:05 KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday - Amber International (NASDAQ:AMBR), Baidu (NASDAQ:BIDU)
Investor's Business Daily 13:12 KalVista Ends Its Unexpectedly Messy Path To Approval In HAE Treatment
Investing 12:22 US FDA approves KalVista Pharma’s swelling disorder drug, shares rise
Benzinga 11:47 Why Is KalVista Pharmaceuticals Stock Soaring On Monday? - KalVista Pharma (NASDAQ:KALV)
Investing 11:26 KalVista stock soars after FDA approves first oral HAE treatment

1日のレンジ

13.68 14.34

1年のレンジ

7.31 16.32

以前の終値: 13.75
始値: 13.82

買値: 14.05
買値: 14.35

安値: 13.68
高値: 14.34

出来高: 1.843 K

1日の変化: 1.66%
1ヶ月の変化: 24.89%

6ヶ月の変化: 60.39%
1年の変化: -5.32%

30 7月, 水曜日